Alzheimer's dementia (AD) is a degenerative brain disorder characterized mainly by cholinergic failure, but other neuro-transmitters are also deficient especially at late stages of the disease. Misfolded β-amyloid peptide has been identified as a causative agent, however inflammatory changes also play a pivotal role. Even though the most prominent pathology is seen in the cognitive functions, specific abnormalities of the central nervous system (CNS) are also reflected in the periphery, particularly in the immune responses of the body. The aim of this study was to characterize the dopaminergic and serotonergic systems in AD, which are also markedly disrupted along with the hallmark acetyl-choline dysfunction. Peripheral blood mono-nuclear cells (PBMCs) from demented patients were judged against comparison groups including individuals with late-onset depression (LOD), as well as non-demented and non-depressed subjects. Cellular sub-populations were evaluated by mono-clonal antibodies against various cell surface receptors: CD4/CD8 (T-lymphocytes), CD19 (B-lymphocytes), CD14 (monocytes), and CD56 (natural-killer (NK)-cells). The expressions of dopamine D 3 and D 4 , as well as serotonin 5-HT 1A , 5-HT 2A , 5-HT 2B and 5-HT 2C were also assessed. There were no significant differences among the study groups with respect to the frequency of the cellular sub-types, however a unique profound increase in 5-HT 2C receptor exclusively in NK-cells was observed in AD. The disease-specific expression of 5-HT 2C , as well as the NK-cell cyto-toxicity, has been linked with cognitive derangement in dementia. These changes not only corroborate the existence of bidirectional communication between the immune system and the CNS, but also elucidate the role of inflammatory activity in AD pathology, and may serve as potential biomarkers for less invasive and early diagnostic purposes as well.
Introduction
Alzheimer's disease (AD) is a neuro-degenerative disorder representing the most prevalent cause of dementia in the elderly people world-wide (Alzheimer's Association, 2011). The main histo-pathological characteristics comprise extra-cellular deposits of β-amyloid peptide (βAP) forming senile plaques, and neurofibrillary tangles (NFTs) consisting mainly of abnormally phosphorylated tau-protein within affected brain cells (Hardy and Selkoe, 2002) . These features have been associated with the progressive degeneration of cholinergic neurons of the basal forebrain and the loss of acetylcholine transmission in the hippocampus and cerebral cortex (Bartus et al., 1982) , leading to progressive impairment of cognitive functions, especially memory. Behavioral changes are also frequent in AD, causing caregiver stress and increased health expenses (Alzheimer's Association, 2011). These behavioral and psychological symptoms of dementia (BPSD) include a heterogeneous group of non-cognitive changes such as apathy, depression, anxiety and delusions (Hersch and Falzgraf, 2007) . The cholinergic system plays a fundamental role not only in the cognitive derangement, but also in BPSD (Cummings and Back, 1998) . The cholinergic hypothesis, however, is not sufficient per se to explain all symptoms observed in AD (Garcia-Alloza et al., 2005) , therefore other neuro-transmitters are also thought to be involved (Chen et al., 2011a (Chen et al., , 2011b .
Even though technically all transmitter-systems can be altered to some extent during the course of the disease, mainly in late stages, dopamine and serotonin have been strongly correlated with cognitive dysfunctions (Parnetti et al., 2001 ) and BPSD (Garcia-Alloza et al., 2005; Proitsi et al., 2012) . The availability of dopamine D 2 -receptors (D 2 R) is directly associated with cognitive performance (Kemppainen et al., 2003) , however different alterations in the dopaminergic system may result in distinct symptoms. The number of D 2 R is generally reduced in the hippocampus and amygdala in AD patients (Joyce et al., 1993) , but their abundance is also decreased in the caudate nucleus and putamen in AD with Parkinsonism (but not in Parkinson's disease alone) (Joyce et al., 1998) . In contrast, increased D 2 R availability is seen in AD with delusions only (Reeves et al., 2009 ). It has also been hypothesized that an imbalance between the glutamatergic and dopaminergic systems may result in psychotic symptoms (Martorana et al., 2010) .
Impaired serotonergic homeostasis has also been implicated in BPSD, causing depressed mood, anxiety, agitation, restlessness and aggressiveness (Lanari et al., 2006) . Serotonin transmission in general is known to be decreased in AD (Cross et al., 1988) , especially in fibers running from the rostral raphe nuclei to the temporal lobe (Yamamoto and Hirano, 1985) . There are 7 distinct families of serotonin (5-hydroxy-tryptamine, 5-HT) receptors, and various sub-populations have been identified (Pytliak et al., 2011) which have distinct localization both in the central nervous system (CNS) and in the periphery, including in leukocytes. Peripheral blood mono-nuclear cells (PBMCs) express several neuro-transmitter receptors, such as 5-HT, which have been suggested to reflect the status of homologous receptors in the brain (Barbanti et al., 2000) . Immune cells, therefore, have not only been proposed as a model for studying CNS alterations and for investigating possible systemic changes in several neuro-psychiatric disorders based on their receptorial status, but they also play a role in the development of AD. Activated microglial cells and reactive astrocytes are intimately found in and around senile plaques, which along with the appearance of inflammatory markers indicate a state of unique endogenous chronic inflammation in AD caused by βAP deposits (Tan et al., 1999; Dumery et al., 2001; Selkoe 2001) . Characteristic functional changes in cellular blood (including lymphocytes) are being extensively studied, and the inflammatory hypothesis of AD has recently been garnering great interest (Teixeira et al., 2008) .
As dopamine and serotonin are involved in the patho-physiology of AD, and inflammatory reaction plays a significant role in the disease mechanism, previous studies have aimed at assessing the neurotransmitter status of PBMCs in dementia. Reduced D 2 R and unchanged D 1 -receptor density was reported in AD lymphocytes, which correlates with similar findings in the brain (Barbanti et al. 2000) , however little information is available on other sub-types. The aim of this study, therefore, was to evaluate the expression of various neuro-transmitter receptors in PBMCs in order to gather further indirect information on the central dopaminergic and serotoninergic function during dementia, and to develop a reliable and relatively accessible peripheral marker in AD.
Methods

Subjects
This project evaluated 16 elderly patients with clinically probable AD according to the National Institute of Neurological and Communicative Disorders and Stroke, and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) work-group criteria. Because of the similar signs and sometimes over-lapping neuro-psychological symptoms depression may pose a differential diagnostic challenge, 10 patients with late onset depression (LOD) as confirmed by the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria have participated in the study as a comparison group (neuro-psychiatric disease controls). In addition, 8 non-demented and non-depressed agematched individuals were also used as healthy controls based on their former medical history, somatic and neuro-psychiatric examination. All subjects were outpatients of the Jenny Faria Center for the Care of the Elderly and the Women, Universidade Federal de Minas Gerais (UFMG) in Belo Horizonte, Brazil.
All participants were thoroughly evaluated, had no infectious processes, cancer, inflammatory or auto-immune diseases, and had not taken any antibiotics, anti-inflammatory, or immuno-suppressive drugs for at least 6 weeks prior to the study. All individuals, or their relatives when appropriate, provided written informed consent before admission to the study. The protocol was approved by UFMG's Research Ethics Committee.
Samples
Whole blood samples were obtained by veni-puncture using vacuum tubes containing heparin (Greiner Bio-One International: Kremsmünster, Austria). In order to rule out any artifacts caused by circadian rhythm, samples were collected at the same time of the day (between 8:00 and 11:00 am), were kept at room temperature and used within 2 h of being drawn. In an effort to minimize day-to-day variation that might occur when performing cell phenol-typing by flow cytometry, at least 1 representative sample from each of the 3 experimental groups were collected and processed each day.
Study design 2.3.1. Separation of PBMCs
Fresh blood samples were diluted in phosphate-buffered saline (PBS 1:1), gently layered on Ficoll solution (Ficoll-PaquePlus, GE Healthcare Bio-Sciences: Uppsala, Sweden) at room temperature, and centrifuged at 405 ×g for 40 min. The PBMC-containing layer was collected and washed twice in PBS at 4°C. The viable cells, as determined by trypan-blue exclusion, were re-suspended at the concentration of 1 × 10 7 cells/mL in a medium composed of RPMI-1640 (Roswell Park Memorial Institute-1640) with L-glutamine (Sigma-Aldrich: Ayrshire, UK), 40 IU/mL of penicillin, 40 mg/mL of streptomycin, supplemented with 10% of heat-inactivated fetal bovine serum (Invitrogen: Auckland, New Zealand). PBMCs were then transferred to a U-bottom 96-well cell culture cluster (Sarstedt: Nümbrecht, Germany) and maintained in incubator at 37°C at 5% CO 2 for 14 h.
Flow cytometry analysis
PBMCs (2 × 10 7 ) were centrifuged at 330 ×g for 40 min and the supernatant was discarded. Extra-cellular staining was performed using mono-clonal anti-bodies labeled with chromophores such as fluorescein iso-thio-cyanate (FITC), phyco-erythrin (PE), and cychrome-5 (CY5), or biotin.
Cellular sub-populations were identified by incubating PBMCs in anti-CD4-FITC, anti-CD14-FITC, anti-CD56-FITC, anti-CD19-CY5 and anti-CD8-biot (BD Pharmingen: Franklin Lakes, NJ, USA) for 20 min at 4°C, then washed with 0.1% sodium-azide in PBS and fixed with 2% formaldehyde in PBS. Cells labeled with biotinylated anti-bodies (anti-CD8) were incubated with streptavidin-CY5 solution for 15 min at 4°C to enable binding of CY5-labeled streptavidin to biotin.
The primary mono-clonal anti-bodies used for the detection of dopamine (anti-D 3 , anti-D 4 ) (SantaCruz Biotechnology: Santa Cruz, CA, USA) and serotonin (anti-5-HT 1A , anti-5-HT 2A , anti-5-HT 2B and anti-5-HT 2C ) (Santa Cruz Biotechnology: Santa Cruz, CA, USA) receptors were labeled with PE (BD Pharmingen: Franklin Lakes, NJ, USA). After staining with primary anti-bodies, PBMCs were washed with PBS, incubated with secondary anti-bodies conjugated with fluoro-phore Alexa-568 (Invitrogen: Eugene, OR, USA) for 15 min at 4°C, washed with PBS, fixed with 2% formaldehyde in PBS for 30 min at room temperature, centrifuged and re-suspended in PBS for acquisition.
FITC and PE-labeled immune-globulin isotype control antibodies were included in all experiments. The stained cells were acquired using Guava-cytometer (GE Technologies: Hayward, CA, USA).
Data analysis and statistical evaluation
Leukocytes were analyzed for their frequencies of surface marker expression using the program CitoSoft-GuavaExpressPro v5.3 (GE Technologies: Hayward, CA, USA). The frequency of positive cells was analyzed in two gates for each staining: lymphocyte gate and monocyte gate. Limits for the quadrant marker were always set based on negative populations, isotype and secondary antibody controls. Illustrative dot-plots used in the analysis are depicted in Fig. 1 .
Data of cellular sub-types and receptor-expression are presented as frequency (%) and median with range. The Shapiro-Wilk test was used to verify normality: as the data were not normally distributed, statistical analysis was performed using Kruskal-Wallis test. With respect to socio-demographic data, values are given as arithmetic mean ± standard deviation (SD) or frequency (%) and range. Analysis of variance (ANOVA) with post-test was used to compare the mediums of the continuous variables. Evaluation of categorical data was performed by χ 2 -test with Yates's correction. All data were analyzed with SPSS program version 16.0 (IBM Corporation: Somers, NY, USA) as well as GraphPad Prism version 4.0 for Windows (GraphPad Software Inc: LaJolla, CA, USA). The level of significance was set at Pb 0.05 for all analyses.
Results
The characteristics of the study populations are described in Table 1 . There was no difference between the groups regarding age, sex or years of education. AD patients had the worst cognitive performance as confirmed by the mini-mental state examination (MMSE), which is an indicative of their dementia. MMSE of LODs was higher than in AD, but lower than that seen with control subjects. Even though this confirms a degree of cognitive impairment in LOD (Wilkins et al., 2009 ), however it is not sufficient enough for these and natural-killer (NK)-cells (CD56 + ) in each patient population (Table 2 ). The study groups demonstrated similar dopamine D 3 -and D 4 -receptor expressions in all cell types (Table 3 ). The abundance of 5-HT 2C receptors in NK-cells was markedly higher in AD patients when compared to controls or LODs (P =0.02, Fig. 2 ), however the rest of the serotonin-receptors (5-HT 1A , 5-HT 2A , and 5-HT 2B ) showed no statistical difference in any cells of any participant (Table 3 ). The finding remained significant after stratification for all variables.
BPSD was present in 25% of AD patients. The dopaminergic and serotonergic receptor-profile in the BPSD + sub-group was similar to that seen in the whole AD group.
Discussion
The probable diagnosis of AD is based on clinical manifestations and is only confirmed during autopsy following a microscopic examination of the brain (Dubois et al., 2007) . There is an urgent unmet need for an objective method to support a definite ante-mortem diagnosis. Cerebral biopsy is not possible for obvious reasons, but AD is known to be a systemic disease with the most prominent changes in the memory functions. Therefore, interest has been focusing on peripheral tissues including lymphocytes (Nagai et al., 1996; Giorelli et al., 2005; Rodrigues et al., 2005; Kumar and Patel 2007; Reale et al., 2008; Torres et al., 2009) . Indeed, as PBMCs are known to reflect changes in the CNS, peripheral immune cells have been widely used to monitor cerebral pathologies, including AD (Dolman, 1984; Idoate-Gastearena and Vega-Vázquez, 1997; Connolly, 1998; Etcheberrigaray et al., 1998; Andrews and Neises, 2012 ). An appropriate marker (or set of markers), therefore, will not only help early diagnosis in AD, but might also be used to evaluate progression and response to treatment. Studies have so far failed to identify such biomarkers that would be both selective and specific for AD.
Even though acetyl-choline deficiency is the primary neuro-chemical alteration, other neuro-transmitters are also affected in AD. Dysfunctional dopaminergic and serotoninergic systems are well characterized in the CNS, but peripheral changes are still under extensive research. It is known that PBMCs express neuro-transmitter receptors and might reflect characteristic changes of the diseased brain. A radio-ligand binding assay study has reported low density of dopamine D 2 -like receptors on AD lymphocytes (Barbanti et al., 2000) , however their expression is also known to be altered in schizophrenia (Vogel et al., 2004; Boneberg et al., 2006) and depression (Rocca et al., 2002) , including bipolar disorder (Vogel et al., 2004) . Another study showed that 5-HT 2A changes in AD platelets are similar to that seen in vascular dementia and in the normal aging brain (Spigset et al., 2000) . This current report has investigated dopamine and serotonin receptor expressions of PBMCs in AD. No differences were found among the study groups, except for 5-HT 2C receptor which was increased in NK-cells of AD patients (Table 3) . Because dopaminergic and mainly serotonergic systems are known to be altered in several other neuro-psychiatric disorders as well, especially in depression, LOD subjects were also evaluated in this study. There was no receptorial change in any cells derived from LOD, suggesting that the over-expression of 5-HT 2C in NK-cells is specific in AD.
Increased 5-HT 2C abundance can reflect decreased serotonin-levels, and might be a compensatory mechanism following reduced serotonin availability. Low serotonin levels are known to explain symptoms of BPSD, especially depressed mood, anxiety, agitation, restlessness and aggressiveness (Lanari et al., 2006) . Interestingly, although affective disorders are typically also related to serotonin dysfunctions, LOD patients demonstrated no 5-HT 2C changes. It is pertinent to mention that the altered 5-HT 2C status of NK-cells in this study was detected independently from the presence or absence of BPSD in the participants. Consequently, the observed finding may serve as a candidate biomarker in AD, but further studies are warranted in this regard.
The disrupted expression of 5-HT 2C was observed exclusively in NK-cells. More than a mere neuro-chemical deficit, this demonstrates an altered inflammatory system in AD with notable implications. Apart from T-lymphocytes, NK-cells are one of the main producers of immune-stimulatory interferon-γ (INF-γ) which has the ability to directly inhibit viral replication. NK-cells, therefore, are important effectors of the innate immune response against viral infections (Trinchieri, 1989) . Functional abnormalities of NK-cells in dementia are also well characterized and known to play some role in the neuroinflammation seen in AD (Araga et al., 1990 (Araga et al., , 1991 Solerte et al., 2000; Masera et al., 2002) . Serotonin is recognized to inhibit NK-cellinduced cyto-toxicity in a dose-dependent manner through 5-HT 2C (Garssadi et al., 1993 , Oláh et al., 2005 ). An over-expression of 5-HT 2C , therefore, leads to decreased NK-activity which could explain earlier associations between AD and viral (especially cerebral) infections (Corder et al., 1998; Martin et al., 2011; Sy et al., 2011) , confirming the theory that the development of AD might be triggered by viral inflammation (Esiri 1982; Miklóssy 2011) . In contrast, NK-cell-derived INF-γ activates indole-amine-2,3-dioxygenase, the enzyme that degrades serotonin precursor tryptophan (Maes et al., 2011) . As such, activation of NK-cells may lead to decreased serotonin levels which in turn might cause over-expression of 5-HT 2C in NK-cells. Such a compensatory mechanism following reduced serotonin availability, however, would also trigger changes in other serotonin-receptors and in other subpopulations of PBMCs, not only 5-HT 2C in NK-cells. Moreover, studies on blood and CSF levels, as well as genotype analyses, have failed to demonstrate any differences of INF-γ in AD (Engelborghs et al., 1999; Fehér et al., 2010; Llano et al., in press) . Taken together, the current finding of 5-HT 2C in NK-cells is not attributable to cytokine response or other compensatory mechanisms, but truly reflect an AD-specific change.
Limitations of this study include the small sample size, and the fact that participants used medications that could not be discontinued for obvious ethical and clinical considerations. Anti-cholin-estherases Reale et al., 2004; Shearman et al., 2006; Calciano et al., 2010) , anti-psychotics (Chen et al., 2011a (Chen et al., , 2011b , benzodiazepines and anti-depressants (Xia et al., 1996) are known to alter serotonin-levels and various immune parameters, although these reports are rather conflicting. As AD and LOD patients may generally use such drugs, the observed findings might also be caused or influenced by their ongoing treatments, however the only significant and important finding was with the 5-HT 2C in NK-cells and not with any of the other serotonin-receptor subtypes or PBMC sub-populations examined which raises the possibility that the observed change is not clearly a drug-effect.
Despite these limitations, this study -to the best knowledge of the authors -reports for the first time about significantly increased 5-HT 2C in AD, explicitly in NK-cells. The observed AD-specific neurotransmitter status of peripheral cells may serve as a potential biomarker for less invasive and early diagnostic purposes. These findings also support the existence of bi-directional communication that occurs between the immune system and CNS, and may also address the yet unexplained viral theory of AD and the participation of the inflammatory system in the patho-physiology of the disease.
